Showing 20 of 56 recruiting trials for “vaginal-carcinoma”
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
👨⚕️ Suzette Delaloge, MD, Gustave Roussy, Veillejuif, France📍 1 site📅 Started Mar 2026View details ↗
Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Retifanlimab and Ruxolitinib In Solid Malignancies
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
Enrolling by InvitationNCT06885424 ↗
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
RecruitingNCT06955910 ↗
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
👨⚕️ Roberto Iacovelli, M.D.; Ph.D., Catholic University of Rome, Italy📍 1 site📅 Started Jun 2025View details ↗
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
🏥 AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT06916624 ↗
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
RecruitingNCT07024680 ↗
Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
👨⚕️ Siddharth A Padia, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Dec 2024View details ↗
Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →